An oral bait vaccination approach for the Tasmanian devil facial tumor diseases

  title={An oral bait vaccination approach for the Tasmanian devil facial tumor diseases},
  author={Andrew S. Flies and E. Flies and S. Fox and A. Gilbert and S. Johnson and Guei-Sheung Liu and A. B. Lyons and Amanda L. Patchett and D. Pemberton and Ruth J Pye},
  journal={Expert Review of Vaccines},
  pages={1 - 10}
ABSTRACT Introduction: The Tasmanian devil (Sarcophilus harrisii) is the largest extant carnivorous marsupial. Since 1996, its population has declined by 77% primarily due to a clonal transmissible tumor, known as devil facial tumor (DFT1) disease. In 2014, a second transmissible devil facial tumor (DFT2) was discovered. DFT1 and DFT2 are nearly 100% fatal. Areas covered: We review DFT control approaches and propose a rabies-style oral bait vaccine (OBV) platform for DFTs. This approach has an… Expand
10 Citations
A transmissible cancer shifts from emergence to endemism in Tasmanian devils
  • 2
Tasmanian devil CD28 and CTLA4 capture CD80 and CD86 from adjacent cells.
  • PDF
Pertussis Vaccines and Vaccination Strategies. An Ever-Challenging Health Problem.
  • A. Cassone
  • Medicine
  • Advances in experimental medicine and biology
  • 2019
Ecological and Evolutionary Challenges for Wildlife Vaccination
  • PDF


Devil Facial Tumours: Towards a Vaccine
  • 5
Biting injuries and transmission of Tasmanian devil facial tumour disease.
  • 108
The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer
  • 206
  • PDF
Distribution and Impacts of Tasmanian Devil Facial Tumor Disease
  • 172
  • PDF
Regression of devil facial tumour disease following immunotherapy in immunised Tasmanian devils
  • 39
  • PDF
Reduced effect of Tasmanian devil facial tumor disease at the disease front.
  • 67